In CRC, elevated PRMT1 expression is positively associated with meR206–PGK1 and pS203–PGK1, indicating a bad prognosis, and it may serve as a combination biomarker to inform the application of methyltransferase inhibitors [72]. The gene discussed is PGK1; the disease is colorectal carcinoma.